In pregnancy, how does ART affect maternal outcomes and the risk of transmitting HIV to the baby?

Prepare for the NCLEX HIV/AIDS Test. Study with interactive multiple choice questions featuring explanations and insights. Boost your readiness for the exam!

Multiple Choice

In pregnancy, how does ART affect maternal outcomes and the risk of transmitting HIV to the baby?

Explanation:
Antiretroviral therapy during pregnancy works by suppressing HIV replication, which both improves the mother’s health and dramatically reduces the risk of transmitting the virus to the baby. When the viral load is kept low, the amount of virus in blood and genital secretions drops, decreasing the chance that the baby will acquire HIV during pregnancy, labor, delivery, or breastfeeding (if breastfeeding occurs). This is why ART is started as early as possible in pregnancy and continued adherently to maintain viral suppression, leading to better maternal outcomes and a much lower risk of mother-to-child transmission. While individual drugs have safety considerations, the overall effect of ART in pregnancy is beneficial for both mother and child.

Antiretroviral therapy during pregnancy works by suppressing HIV replication, which both improves the mother’s health and dramatically reduces the risk of transmitting the virus to the baby. When the viral load is kept low, the amount of virus in blood and genital secretions drops, decreasing the chance that the baby will acquire HIV during pregnancy, labor, delivery, or breastfeeding (if breastfeeding occurs). This is why ART is started as early as possible in pregnancy and continued adherently to maintain viral suppression, leading to better maternal outcomes and a much lower risk of mother-to-child transmission. While individual drugs have safety considerations, the overall effect of ART in pregnancy is beneficial for both mother and child.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy